Evidence map›Paper›PMID 40000627›Full record

ArticleNature communications2025

Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidation.

André Gollowitzer, Helmut Pein, Zhigang Rao, Lorenz Waltl, Leonhard Bereuter, Konstantin Loeser, Tobias Meyer, Vajiheh Jafari, Finja Witt, René Winkler and 25 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. NewInternational journal of molecular sciences · 2026
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

André Gollowitzer *Michael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-1524-8298
Helmut Pein *Chair of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, 07743, Jena, Germany.
Zhigang RaoMichael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-9918-9100
Lorenz WaltlMichael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.
Leonhard BereuterMichael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0009-0006-1790-1288
Konstantin LoeserChair of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, 07743, Jena, Germany.
Tobias MeyerInstitute of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller-University Jena, 07743, Jena, Germany.
Vajiheh JafariChair of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, 07743, Jena, Germany.
Finja WittMichael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.
René WinklerDepartment of Biochemistry, Center for Molecular Biomedicine (CMB), Friedrich-Schiller-University Jena, 07745, Jena, Germany.ORCID http://orcid.org/0000-0002-7570-0242
Fengting SuMichael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0009-0001-6430-9221
Silke GroßeInstitute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Jena University Hospital, 07745, Jena, Germany.ORCID http://orcid.org/0000-0002-6218-033X
Maria ThürmerChair of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, 07743, Jena, Germany.ORCID http://orcid.org/0000-0002-7075-5260
Julia GranderMichael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-5330-7503
Madlen HotzeInstitute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0009-0001-1816-2089
Sönke HarderInstitute of Clinical Chemistry and Laboratory Medicine, Section Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.ORCID http://orcid.org/0000-0002-6352-4771
Lilia EspadaLeibniz Institute on Aging - Fritz Lipmann Institute (FLI), 07745, Jena, Germany.
Alexander MagnutzkiADSI-Austrian Drug Screening Institute, University of Innsbruck, 6020, Innsbruck, Austria.
Ronald GstirADSI-Austrian Drug Screening Institute, University of Innsbruck, 6020, Innsbruck, Austria.
Christina WeinigelInstitute of Transfusion Medicine, University Hospital Jena, 07747, Jena, Germany.
Silke RummlerInstitute of Transfusion Medicine, University Hospital Jena, 07747, Jena, Germany.
Günther BonnADSI-Austrian Drug Screening Institute, University of Innsbruck, 6020, Innsbruck, Austria.
Johanna PachmayrInstitute of Pharmacy, Paracelsus Medical University, 5020, Salzburg, Austria.
Maria ErmolaevaLeibniz Institute on Aging - Fritz Lipmann Institute (FLI), 07745, Jena, Germany.ORCID http://orcid.org/0000-0002-2108-2610
Takeshi HarayamaInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur - CNRS UMR7275 - Inserm U1323, 06560, Valbonne, France.ORCID http://orcid.org/0000-0003-2255-4197
Hartmut SchlüterInstitute of Clinical Chemistry and Laboratory Medicine, Section Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.ORCID http://orcid.org/0000-0002-9358-7036
Christian KosanDepartment of Biochemistry, Center for Molecular Biomedicine (CMB), Friedrich-Schiller-University Jena, 07745, Jena, Germany.ORCID http://orcid.org/0000-0002-8387-3653
Regine HellerInstitute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Jena University Hospital, 07745, Jena, Germany.ORCID http://orcid.org/0000-0002-1703-1925
Kathrin ThedieckInstitute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-9069-2930
Michael SchmittInstitute of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller-University Jena, 07743, Jena, Germany.ORCID http://orcid.org/0000-0002-3807-3630
Takao ShimizuDepartment of Lipid Signaling, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Jürgen PoppInstitute of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller-University Jena, 07743, Jena, Germany.
Hideo ShindouDepartment of Lipid Life Science, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Marcel KwiatkowskiInstitute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, 6020, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-5804-6031
Andreas KoeberleMichael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020, Innsbruck, Austria. andreas.koeberle@uni-graz.at.ORCID http://orcid.org/0000-0001-6269-5088

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P 36299Deutsche Forschungsgemeinschaft (German Research Foundation) GRK 1715Deutsche Forschungsgemeinschaft (German Research Foundation) KO 4589/4-1Friedrich-Schiller-Universität Jena (Friedrich Schiller University Jena) 2.7-05Friedrich-Schiller-Universität Jena (Friedrich Schiller University Jena) DRM/2013-05Phospholipid Research Center AKO-2015-037/1-1Phospholipid Research Center AKO-2019-070/2-1Phospholipid Research Center AKO-2O22-100/2-2
6 · The paper itself

Abstract

Cell death programs such as apoptosis and ferroptosis are associated with aberrant redox homeostasis linked to lipid metabolism and membrane function. Evidence for cross-talk between these programs is emerging. Here, we show that cytotoxic stress channels polyunsaturated fatty acids via lysophospholipid acyltransferase 12 into phospholipids that become susceptible to peroxidation under additional redox stress. This reprogramming is associated with altered acyl-CoA synthetase isoenzyme expression and caused by a decrease in growth factor receptor tyrosine kinase (RTK)-phosphatidylinositol-3-kinase signaling, resulting in suppressed fatty acid biosynthesis, for specific stressors via impaired Akt-SREBP1 activation. The reduced availability of de novo synthesized fatty acids favors the channeling of polyunsaturated fatty acids into phospholipids. Growth factor withdrawal by serum starvation mimics this phenotype, whereas RTK ligands counteract it. We conclude that attenuated RTK signaling during cell death initiation increases cells' susceptibility to oxidative membrane damage at the interface of apoptosis and alternative cell death programs.

Indexed as

Cell MembraneIntercellular Signaling Peptides and ProteinsLipid PeroxidationSignal TransductionAnimalsApoptosisCell DeathCoenzyme A LigasesFatty AcidsFerroptosisHumansMiceOxidation-ReductionOxidative StressPhospholipidsProto-Oncogene Proteins c-aktCoenzyme A LigasesFatty AcidsIntercellular Signaling Peptides and ProteinsPhospholipidsProto-Oncogene Proteins c-aktReceptor Protein-Tyrosine Kinases

Identifiers

PMID40000627
PMCPMC11861335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.